Linking Proteostasis to Epigenetic Reprogramming and the Metastatic Niche In SPOP-Mutated Prostate Cancer
Serican Journal of Medicine · 20.11.2026 · 3 (4)
DOI: 10.17161/sjm.v3i4.26289 ↗Kurz gefasst
Fachartikel in der Zeitschrift Serican Journal of Medicine, online erschienen am 20.11.2026. Verfasst von Di Zhao und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Commentary on Meng et al. “Dysregulated ASH1L-MUC1-CD133 Axis Promotes Lung Metastasis and Reprograms the Metastatic Niche in SPOP-deficient Prostate Cancer”, which is accepted for publication in Oncogene.
Zitieren
APA
Zhao, D., Alexander, T., & Qianlin, G. (2026). Linking Proteostasis to Epigenetic Reprogramming and the Metastatic Niche In SPOP-Mutated Prostate Cancer. Serican Journal of Medicine, 3(4). https://doi.org/10.17161/sjm.v3i4.26289
Vancouver
Zhao D, Alexander T, Qianlin G. Linking Proteostasis to Epigenetic Reprogramming and the Metastatic Niche In SPOP-Mutated Prostate Cancer. Serican Journal of Medicine. 2026;3(4). doi:10.17161/sjm.v3i4.26289
BibTeX
@article{Zhao2026,
author = {Zhao, Di and Alexander, Tang and Qianlin, Gu},
title = {Linking Proteostasis to Epigenetic Reprogramming and the Metastatic Niche In SPOP-Mutated Prostate Cancer},
journal = {Serican Journal of Medicine},
year = {2026},
volume = {3},
number = {4},
doi = {10.17161/sjm.v3i4.26289}
}
EUVIMED